

Forrestiacids C and D, unprecedented triterpene-diterpene adducts from Pseudotsuga forrestii
English
Forrestiacids C and D, unprecedented triterpene-diterpene adducts from Pseudotsuga forrestii
-
Key words:
- Forrestiacid
- / Pseudotsuga forrestii
- / Pinaceae
- / Michael adduct
- / Lipogenesis inhibitor
-
Pinaceae, the largest conifer family with 220 to 250 species assigned to 11 genera and are distinctive in being primarily trees rather than shrubs [1]. Species of the Pinaceae are among the most valuable and commercially important plants (e.g., cedar, fir, larch, pine, and spruce). This family has also attracted great interest for higher potential in the field of natural products drug discovery. A survey unveiled that Pinaceae ranked among the top-20 privileged drug-prolific families that produced high numbers of approved drugs [2].
Highly concerning is that 34% of the conifer species worldwide are currently threatened with extinction [3]. As for Pinaceae, there are 39 species recorded in the first volume of the China Plant Red Data Book (CPRDB). This signifies that this family occupies a great proportion (ca. 10%) of this reference, which listed a total of 388 species [4]. Plant diversity loss significantly exacerbates the complications in the discovery of new natural products-derived drugs owing to the rare and endangered plants (REPs) being better botanical sources [2, 5, 6]. An important goal for the conservation of the endangered plants is to provide key resources for researchers for new chemistry with utility in the control of new and emerging drug targets [7]. Thus, there is an urgent need to prioritize protection and utilization of these fragile plant species. In recent years, we have paid special attention to rare and endangered coniferous plants native to China [8]. In particular, REPs in the Pinaceae family have aroused an extra interest [9, 10], due to their high potency in drug discovery, relatively other species diversity, and easier sample collections from the renewable needles and twigs from these large trees distributed and managed in the wild or cultivated in botanic gardens.
As a small genus in Pinaceae, Pseudotsuga comprises only a few recognized species distributed in the northern hemisphere, demonstrating a typical eastern Asia and western North America disjunct distribution patterns [4, 11]. The type species P. menziesii, Douglas-fir, is one of the most economically important timbers in the world [11]. In China, there are five endemic Pseudotsuga species (i.e., Asian Douglas-fir) or varieties: P. forrestii, P. sinensis, P. brevifolia, P. gaussenii, and P. wilsoniana [1]. All these species are recorded as vulnerable or endangered in CPRDB [4], and have also been nationally protected at the 'second-grade' in China [12].
The relict Pseudotsuga species P. forrestii is distributed within a total area of ca. 5000 km2 (mainly in the Lancang river basin and partly in the Jinsha river basin in south-western China) [1, 4]. Besides timber, P. forrestii has a high ornamental value since its pinecones look like a blooming rose after ripening. In a preceding study on P. forrestii, two unique triterpene–diterpene adducts (forrestiacids A and B, m/z 769 [M + H]+) featuring a novel carbon skeleton formed by intermolecular Diels-Alder cycloadditions between a spiro-lanostane triterpene unit and an abietadiene unit (Fig. S1 in Supporting information), were obtained by the implementation of HR-MS/MS-based molecular ion networking (MoIN) [13]. Further purification of the minor metabolites with the same target pseudo-molecular ion [M + H]+ at m/z 769 by the guidance of MoIN (Fig. S2 in Supporting information) afforded another two unprecedented hetero-dimers (1 and 2) (Fig. 1), but constructed via an intermolecular Michael addition reaction of a rearranged 6/6/5/5-fused spiro-lanostene (C30-unit) with an abietene (C20-unit). The intriguing skeleton features a unique single C—C bond between C-25 (C30-unit) and C-13′ (C20-unit), which is quite different from those in the Diels-Alder adducts (forrestiacids A and B) [13]. Herein, we describe their isolation and structural elucidation, together with the lipogenesis inhibitory activities. This work is the Part XXI in a series of "Phytochemical and biological studies on rare and endangered plants endemic to China" (for Part XX, see ref. [13]).
Figure 1
Forrestiacid C (1), obtained as colorless needles from MeOH, was assigned the molecular formula C50H72O6 as evidenced by the HR-ESI-MS ion at m/z 791.5194 [M + Na]+ (calcd. for C50H72O6Na, 791.5221). In the up-field region of the 1H NMR spectrum of 1, eight singlet methyls and one doublet methyl were observed at δH 0.82 (s, 3H), 0.88 (s, 3H), 0.98 (d, J = 6.5 Hz, 3H), 1.17 (s, 3H), 1.20 (s, 6H), 1.43 (s, 3H), 1.73 (s, 3H), and 2.05 (s, 3H) (Table 1). Two pairs of olefinic proton resonances at δH 4.86/4.65 and 5.28/5.12 (each 1H, br s) arose from two exomethylene groups. The 13C NMR data (Table 1) of 1, with the aid of DEPT 135 and HSQC spectra, revealed 50 carbon resonances ascribable for nine methyls, 19 methylenes, five methines, 13 quaternary carbons, two carboxyls, and two keto-carbonyls. These data highlighted that 1 should be a (C30 + C20) pentaterpene, similar to forrestiacids A and B [13].
Table 1
Comprehensive analyses of the 1D and 2D NMR spectroscopic data of 1 implied the presence of a spiro-lanostane-type tetracyclic triterpenoid and an abietadiene-type diterpenoid unit (Fig. 2). For the triterpenoid part, the rearranged 6/6/5/5-fused spiro-lanostane nucleus bearing a 3-ketocarbonyl group (δC 216.0) and the double allyl nodal [i.e., spiro[4.4]nona-8, 14(30)-diene] motif was evidenced by the COSY and HMBC correlations as depicted in Fig. 2. As for the abietane part, an exomethylene group was located at C-15′ based on the HMBC correlations from H2-16′ (δH 5.28/5.12) to C-15′/C-13′, and from H3-17′ (δH 2.05) to C-13′/C-15′/C-17′ (Fig. 2). Another double bond, being a trisubstituted one [δH 6.36, s (H-14′); δC 138.6 (C-8′), 127.0 (C-14′)] was then elucidated to be sited between C-8′ and C-14′ by the HMBC correlations from H-14′ to C-7′, C-9′, and C-13′. In addition, the two carboxyl groups were assigned to attach to C-4′ and C-25, respectively, on the basis of HMBC cross peaks of H3-19′ with C-4′ and C-18′ (δC 181.2), and of H3-26 with C-25 and C-27 (δC 177.9). The remaining keto-carbonyl group at δC 209.6 was placed at C-23 based on its HMBC correlations with the two pairs of deshielded methylene protons of H2-22 (δH 2.88/2.49) and H2-24 (δH 3.60/2.89).
Figure 2
Moreover, the spiro-lanostane fragment was connected with the abietadiene by the formation of a new carbon–carbon single bond between C-25 and C-13′. This was defined by the HMBC correlations from H3-26 (δH 1.73) to C-24, C-25, C-27, and C-13′.
Further inspection of the ROESY spectrum of 1 (Fig. 3) confirmed that the relative configuration of the spiro-lanostane nucleus was consistent with those of structurally related compounds, such as neoabiestrine F and forrestiacids A and B [13]. Concerning the abietene unit, its relative configuration could be readily assigned as shown in Fig. 3 based on the ROE correlations of H3-19′/H3-20′ and H-5′/H-9′. The isopropenyl group at C-13′ was β-positioned as evidenced by the diagnostic correlation between H3–17′ and H3–20′. However, determination of the stereochemistry at the quaternary carbon C-25 proved challenging due to the absence of available ROESY data for this flexible alkyl chain.
Figure 3
Interestingly, accompanied with 1, its C-25 epimer, forrestiacid D (2), co-occurred in the same subfraction (for details, see Experimental in Supporting information). The molecular formula of 2 was determined to be identical with 1 from the positive-mode HR-ESI-MS ion at m/z 791.5213 [M + Na]+ (calcd. 791.5221). Consistently, the 1H and 13C NMR spectroscopic data of 2 highly resembled those of 1 (Table 1). In terms of the 13C chemical shifts, the largest difference between the two isolates was only 0.5 ppm (C-22, δC 46.3 vs. 45.8). It was similar with the 1H NMR data—there were just two positions where the proton resonances differed by 0.2 and 0.3 ppm (i.e., H-14′ and H-24b, respectively). The aforementioned data suggested that compound 2 should be a diastereoisomer of 1 with a different stereochemistry at C-25 and/or C-13′. This assumption was reinforced by further analyses of the 1H–1H COSY and HMBC spectra, which revealed that 2 did possess the same 2D structure as 1. Similar to 1, a key correlation between H3-17′ and H3-20′ was also observed in the ROESY spectrum of 2, assigning a same relative configuration at C-13′ in both 1 and 2. Taken together, compound 2 was undoubtedly deduced to be a C-25 epimer of 1.
Determination of the C-25 configurations in 1 and 2 was a difficult task. The electronic circular dichroism (ECD) spectra of the two epimers were overlaid with each other (Fig. S3 in Supporting information), precluding the application of ECD calculations. Moreover, the NMR shifts are very similar between 1 and 2, just as described above. The NMR calculations would thus most likely not be able to differentiate between the two epimers. In our experience, NMR calculations commonly produce deviations from 13C NMR experimental values of 1 ppm or more, so the error associated with the calculations are greater than the difference in the NMR shifts between the different epimers. As expected, the results obtained from the preliminary GIAO NMR calculations with DP4+ probability analysis predicted that, the two epimers both matched closely with the calculated data of (25S)-isomer with 100% probability, along with 0% probability for the (25R)-isomer. Hence, in the case of 1 and 2, the quantum NMR computational method also seems ineffectual and powerless. Actually, the limit of NMR calculations for the structural assignment of complex natural products has been well documented by Marcarino et al. [14].
Fortunately, after repeated attempts, a qualified crystal of 1 acquired in MeOH allowed a successful performance of single crystal X-ray diffraction [Flack parameter 0.02(18), Fig. 4]. This unambiguously confirmed the relative and absolute configurations of 1, especially the configuration at C-25 (25S). The whole structure of (5R, 10S, 13R, 17S, 20R, 25S, 4′R, 5′R, 9′S, 10′R, 13′S)-1, was thus unequivocally established as depicted. Accordingly, the absolute configuration of 2 was defined as (5R, 10S, 13R, 17S, 20R, 25R, 4′R, 5′R, 9′S, 10′R, 13′S).
Figure 4
The structural features implied that 1 and 2 would be generated via a Michael addition between a unique spiro-lanostane-type triterpenoid precursor neoabiestrine F (co-occurring in the title plant [13]) and an abietadiene precursor (Scheme 1). The 24-en-23-one group in the side chain of neoabiestrine F would act as the 'Michael acceptor', whereas the diene motif in the diterpenoid would act as the 'Michael donor'.
Scheme 1
Michael addition is one of the most important C—C bond-forming reactions in synthetic organic chemistry. The natural product biosynthetic machinery also uses a Michael-type addition to synthesize structurally diverse bioactive compounds [15]. So far, a number of naturally occurring Michael adducts (e.g., polyketides [16a], cytochalasin homodimer [16b], trimeric macrodiolide [16c], and ent-kauranoid dimers [16d]) with interesting bioactivities have been reported. Among them, the terpenoid homo- or hetero-dimers are quite rare. To our knowledge, only a few have been encountered. For examples, three Michael adducts of ent-kaurane-type diterpenoid homo-dimers from the Isodon species [16d, e]. Forrestiacids C and D are the first two triterpene–diterpene adducts formed by Michael addition and represent an unusual chemical class of terpenoid hetero-dimers.
The efficacy of bempedoic acid [the first ATP-citrate lyase (ACL) inhibitor approved by Food and Drug Administration (FDA)] as a low-density lipoprotein cholesterol (LDL-C)-lowering agent, has validated ACL inhibition as a therapeutic strategy for glycolipid metabolic disorders (e.g., hyperlipidemia and hypercholesterolemia) [17, 18]. In our previous study, forrestiacids A and B, the two [4 + 2]-adducts exhibited potent inhibitory effects against ACL, and elicited dual inhibition on the fatty acid and cholesterol syntheses in HepG2 cells [13]. Continuing our studies on the discovery of novel ACL and lipogenesis inhibitors from natural products, compounds 1 and 2 were evaluated for their ACL inhibitory effects. As illustrated in Table 2, they both displayed remarkable inhibition on ACL, with 50% inhibiting concentration (IC50) values of 10.99 and 22.78 µmol/L, respectively. BMS 303141 was used as the positive control (IC50: 0.46 ± 0.13 µmol/L). Interestingly, bempedoic acid and forrestiacids A–D all are dicarboxylic acid derivatives. Compared with the Diels-Alder adducts forrestiacids A and B (IC50s < 5 µmol/L) [13], the Michael adducts (1, 2), with the absence of a bridged-ring system (Fig. S1), showed relatively weaker inhibitory effects against ACL, although they have the same molecular weight. In addition, the 25S-isomer (1) demonstrated more potent inhibitory effect on ACL than its epimer (2). Interestingly, the 25S-isomer (1) also displayed significant inhibition (IC50: 7.84 µmol/L) against acetyl-CoA carboxylase 1 (ACC1), which is also one of the rate-limiting enzymes in fatty acid synthesis by converting acetyl-CoA to malonyl CoA [19]. ACC1 has been considered as a potential drug target for glycolipid metabolic disorders (especially for hepatic steatosis). It is worth mentioning that, only slight inhibitory effects on ACL and ACC1 were found for the triterpene precursor neoabiestrine F, with IC50 values of 24.33 and 24.40 µmol/L, respectively. Taken together, the above findings indicated that the chirality of C-25 in forrestiacids C and D might play an important role in the lipogenesis inhibition of these Michael adducts, which warrants further investigations.
Table 2
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
This work was supported by grants from the National Natural Science Foundation of China (Nos. 21937002, 81773599, 21772025). The authors thank Prof. Mark T. Hamann (Medical University of South Carolina, USA) and Dr. Yike Zou (Department of Chemistry and Biochemistry, University of California, at Los Angeles, USA) for their kind suggestions and assistance with the NMR quantum computations.
-
-
[1]
(a) L.K. Fu, N. Li, R.R. Mill, In: Z.Y. Wu, P.H. Raven, (Eds. ). Flora of China, Science Press (Beijing) & Missouri Botanical Garden Press (St. Louis), 4 (1999), pp 11–52.
(b)The Plant List, Version 1.1. A Working List for All Plant Species, The Plant List 2013. http://www.theplantlist.org/1.1/browse/G/Pinaceae/. -
[2]
F. Zhu, C. Qin, L. Tao, et al., Proc. Natl. Acad. Sci. U.S.A. 108 (2011) 12943–12948. doi: 10.1073/pnas.1107336108
-
[3]
The IUCN Red List of Threatened Species, Version 2021-3. https://www.iucnredlist.org.
-
[4]
L.K. Fu, J.M. Jin, China Plant Red Data Book. Rare and Endangered Plants I, Science Press, Beijing and New York, 1992.
-
[5]
M.A. Ibrahim, M. Na, J. Oh, et al., Proc. Natl. Acad. Sci. U.S.A. 110 (2013) 16832–16837. doi: 10.1073/pnas.1311528110
-
[6]
S.H.M. Butchart, M. Walpole, B. Collen, et al., Science 328 (2010) 1164–1168. doi: 10.1126/science.1187512
-
[7]
J.L. Fox, Science 226 (1984) 150. doi: 10.1126/science.226.4671.150.a
-
[8]
G.L. Ma, N. Guo, X.L. Wang, et al., Bioorg. Chem. 105 (2020) 104445.
-
[9]
W. Jiang, J. Xiong, Y. Zang, et al., Phytochemistry 169 (2020) 112161. doi: 10.1016/j.phytochem.2019.112161
-
[10]
T. Huang, S.H. Ying, J.Y. Li, et al., Phytochemistry 169 (2020) 112184. doi: 10.1016/j.phytochem.2019.112184
-
[11]
X.X. Wei, Z.Y. Yang, Y. Li, et al., Mol. Phylogenet. Evol. 55 (2010) 776–785. doi: 10.1016/j.ympev.2010.03.007
-
[12]
National Forestry and Grassland Administration. List of National Key Protected Wild Plants 2021, http://www.gov.cn/zhengce/zhengceku/2021-09/09/content_5636409.htm.
-
[13]
J. Xiong, P.J. Zhou, H.W. Jiang, et al. Angew. Chem. Int. Ed. 60 (2021) 22270–22275. doi: 10.1002/anie.202109082
-
[14]
M.O. Marcarino, S. Cicetti, M.M. Zanardi, et al., Nat. Prod. Rep. 39 (2022) 58–76. doi: 10.1039/d1np00030f
-
[15]
(a) A. Michael, J. Prakt. Chem. 35 (1886) 349–356;
(b) P. Perlmutter, Conjugate Addition Reactions in Organic Synthesis, Pergamon Press, Oxford, 1992. -
[16]
(a) A. Miyanaga, Nat. Prod. Rep. 36 (2019) 531–547;
(b) Z. Wu, X. Zhang, C. Chen, et al., Org. Lett. 22 (2020) 2162–2166;
(c) T.T. Wang, Y.J. Wei, H.M. Ge, et al., Org. Lett. 20 (2018) 2490–2493;
(d) H.B. Zhang, J.X. Pu, Y. Zhao, et al., Tetrahedron Lett. 52 (2011) 6061–6066;
(e) Y. Zhao, S.X. Huang, W.L. Xiao, et al., Tetrahedron Lett. 50 (2009) 2019–2023. -
[17]
(a) K.H.G. Verschueren, C. Blanchet, J. Felix, et al., Nature 568 (2019) 571–575;
(b) K.E. Wellen, G. Hatzivassiliou, U.M. Sachdeva, et al., Science 324 (2009) 1076–1080. -
[18]
(a) K.K. Ray, H.E. Bays, A.L. Catapano, et al., N. Engl. J. Med. 380 (2019) 1022–1032;
(b) S.L. Pinkosky, R.S. Newton, E.A. Day, et al., Nat. Commun. 7 (2016) 13457. -
[19]
M. Hunkeler, A. Hagmann, E. Stuttfeld, et al., Nature 558 (2018) 470–474. doi: 10.1038/s41586-018-0201-4
-
[1]
-
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR data (δ in ppm, J in Hz, in pyridine-d5) for 1 and 2.
Table 2. Inhibitory activities of 1 and 2 against ACL and ACC1.
-

计量
- PDF下载量: 2
- 文章访问数: 584
- HTML全文浏览量: 30